Pulmonary, Critical Care and Sleep Medicine
The Section of Pulmonary, Critical Care, and Sleep Medicine at Baylor College of Medicine is nationally recognized for its excellence in healthcare, research and education.
The section has total research support of $4.8 million from federal and private research grants including lung cancer, asthma, COPD, pulmonary hypertension, pulmonary fibrosis, transitional medicine, lung transplant, and cystic fibrosis.
Many physicians from the section are national and international experts. Together, they offer an incredibly large array of services, from general pulmonary and sleep medicine to highly specialized advanced lung diseases, such as including pulmonary hypertension, pulmonary fibrosis, adult cystic fibrosis, COPD/asthma, interstitial lung disease, lung and heart-lung transplantation, critical care, and interventional pulmonology.
The section offers four fellowship programs, including Pulmonary & Critical Care, Critical Care Medicine, Lung Transplantation, and Sleep Medicine. Many alumni and former fellows can be found in academic, research and healthcare leadership roles.
- Dr. Huda Zoghbi honored for distinguished achievement in developmental psychobiology Mar 27, 2015
- Baylor College of Medicine pioneering scientist Dr. Huda Zoghbi is this year’s recipient of the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology.
- Experts ramp up efforts to improve TB testing in childrenMar 24, 2015
- Experts from around the world, including Baylor, call for continued and increased focus on providing more accurate tuberculosis testing.
- Ellis receives ASCO award for contributions to breast cancer genomics research, mentorshipMar 23, 2015
- Dr. Matthew Ellis has been named recipient of the 2015 American Society of Clinical Oncology’s Gianni Bonadonna Breast Cancer Award and Lecture.
- Put a lid on it: Improper storage of makeup could lead to infectionMar 23, 2015
- Not storing makeup properly and using out-of-date cosmetics can result in infection, said dermatology experts at Baylor College of Medicine.
- First evaluation of HER2-specific ‘killer’ T cells in humansMar 23, 2015
- A clinical trial has shown promise for a new type of immunotherapy treatment for patients with HER2-positive sarcoma and may extend to other types of cancer.